This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 35 and 85
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of the study is to compare the efficacy and safety of flavocoxid (Limbrel) with Naproxen and placebo in OA of the knee.

Provided treatments

  • : Flavocoxid 500 mg
  • Drug: Naproxen
  • Other: Placebo
  • Other: flavocoxid 250 mg
Tris trial is registered with FDA with number: NCT00928837. The sponsor of the trial is Primus Pharmaceuticals and it is looking for 350 volunteers for the current phase.
Official trial title:
A Double-Blind,Randomized, Placebo Controlled, Parallel Group, Multi-Center Study of Flavocoxid (Limbrel) Versuss Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee